Oral Mucositis Market Research Report - Forecast till 2027

Oral Mucositis Market Size, Growth and Trends By Cause (Oral Mucositis Caused by Chemotherapy, Oral Mucositis Caused by Radiotherapy, Oral Mucositis Caused by Hematopoietic Stem Cell Transplantation, and Others ), End-User (Hospitals, Dental Clinics, Oncology Hospitals, and Research Institutes), and Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2027

ID: MRFR/Pharma/1002-HCR | August 2022 | Region: Global | 80 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

Chapter 5. Market Factor Analysis

5.1 Porterโ€™s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Oral Mucositis Market, by Cause

6.1 Overview

6.2 Oral Mucositis Caused by Chemotherapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3 Oral Mucositis Caused by Radiotherapy

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4 Oral Mucositis Caused by Hematopoietic Stem Cell Transplantation

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5 Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 7. Global Oral Mucositis Market, by End Use

7.1 Overview

7.2 Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2 Dental Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2 Oncology Hospitals

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.2 Research Institutes

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

Chapter 8. Global Oral Mucositis Market, by Region

8 .1 Overview

8 .2 Americas

8 .2.1 North America

8 .2.1.1 US

8 .2.1.2 Canada

8 .2.2 Latin America

8 .3 Europe

8 .3.1 Western Europe

8 .3.1.1 Germany

8 .3.1.2 France

8 .3.1.3 Italy

8 .3.1.4 Spain

8 .3.1.5 UK

8 .3.1.6 Rest of Western Europe

8 .3.2 Eastern Europe

8 .4 Asia-Pacific

8 .4.1 Japan

8 .4.2 China

8 .4.3 India

8 .4.4 Australia

8 .4.5 South Korea

8 .4.6 Rest of Asia-Pacific

8 .5 Middle East & Africa

8 .5.1 Middle East

8 .5.2 Africa

Chapter 9. Company Landscape

9.1 Overview

9.2 Competitive Analysis

Chapter 10. Company Profile

10.1 Izun Pharmaceuticals Corporation

10.1.1 Company Overview

10.1.2 Product Type Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Shoreline Pharmaceuticals, Inc

10.2.1 Company Overview

10.2.2 Product Type Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 AMAG Pharmaceutical Inc

10.3.1 Company Overview

10.3.2 Product Type Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Innovation Pharmaceuticals

10.4.1 Company Overview

10.4.2 Product Type Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 The Himalaya Drug Company

10.5.1 Company Overview

10.5.2 Product Type Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Access pharmaceuticals

10.6.1 Company Overview

10.6.2 Product Type Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 EKR therapeutics Inc

10.7 .1 Overview

10.7 .2 Product Type Overview

10.7 .3 Financial Overview

10.7 .4 Key Developments

10.7 .5 SWOT Analysis

10.8 EUSA Pharma Inc

10.8.1 Overview

10.8.2 Product Type Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Swedish Orphan Biovitrum AB (publ)

10.9.1 Overview

10.9.2 Product Type Overview

10.9.3 Financials

10.9.4 Key Developments

10.9.5 SWOT Analysis

10.10 Soligenix

10.10.1 Overview

10.10.2 Product Type Overview

10.10.3 Financials

10.10.4 Key Developments

10.10.5 SWOT Analysis

10.11 Daewoong co Ltd

10.11.1 Overview

10.11.2 Product Type Overview

10.11.3 Financials

10.11.4 Key Developments

10.11.5 SWOT Analysis

10.12 Others

Chapter 11 Appendix

11.1 References

11.2 Related Reports

โ€ƒ

LIST OF TABLES

Table 1 Global Oral Mucositis Market Synopsis, 2020-2027

Table 2 Global Oral Mucositis Market Estimates and Forecast, 2020-2027 (USD Million)

Table 3 Global Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 4 Global Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 5 Global Oral Mucositis Market, by Region, 2020-2027 (USD Million)

Table 6 North America: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 7 North America: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 8 US: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 9 US: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 10 Canada: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 11 Canada: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 12 Latin America: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 13 Latin America: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 14 Europe: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 15 Europe: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 16 Western Europe: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 17 Western Europe: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 18 Eastern Europe: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 19 Eastern Europe: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 20 Asia-Pacific: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 21 Asia-Pacific: Oral Mucositis Market, by End Use, 2020-2027 (USD Million)

Table 22 Middle East & Africa: Oral Mucositis Market, by Cause, 2020-2027 (USD Million)

Table 23 Middle East & Africa: Oral Mucositis Market, by End Use, 2020-2027 (USD Million) โ€ƒ

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Oral Mucositis Market

Figure 3 Market Dynamics for Global Oral Mucositis Market

Figure 4 Global Oral Mucositis Market Share, by Cause, 2020 (%)

Figure 5 Global Oral Mucositis Market Share, by End Use, 2020 (%)

Figure 6 Global Oral Mucositis Market Share, by Region, 2020 (%)

Figure 7 North America: Oral Mucositis Market Share, by Country, 2020 (%)

Figure 8 Europe: Oral Mucositis Market Share, by Region, 2020 (%)

Figure 9 Western Europe: Oral Mucositis Market Share, by Country, 2020 (%)

Figure 10 Asia-Pacific: Oral Mucositis Market Share, by Country, 2020 (%)

Figure 11 Middle East & Africa: Oral Mucositis Market Share, by Country, 2020 (%)

Figure 12 Global Oral Mucositis Market: Company Share Analysis, 2020 (%)

Figure 13 Izun Pharmaceuticals Corporation: Key Financials

Figure 14 Izun Pharmaceuticals Corporation: Segmental Revenue

Figure 15 Izun Pharmaceuticals Corporation: Geographic Revenue

Figure 16 Shoreline Pharmaceuticals, Inc: Key Financials

Figure 17 Shoreline Pharmaceuticals, Inc: Segmental Revenue

Figure 18 Shoreline Pharmaceuticals, Inc: Geographic Revenue

Figure 19 AMAG Pharmaceutical Inc: Key Financials

Figure 20 AMAG Pharmaceutical Inc: Segmental Revenue

Figure 21 AMAG Pharmaceutical Inc: Geographic Revenue

Figure 22 Innovation Pharmaceuticals: Key Financials

Figure 23 Innovation Pharmaceuticals: Segmental Revenue

Figure 24 Innovation Pharmaceuticals: Geographic Revenue

Figure 25 The Himalaya Drug Company: Key Financials

Figure 26 The Himalaya Drug Company: Segmental Revenue

Figure 27 The Himalaya Drug Company: Geographic Revenue

Figure 28 Access pharmaceuticals: Key Financials

Figure 29 Access pharmaceuticals: Segmental Revenue

Figure 30 Access pharmaceuticals: Geographic Revenue

Figure 31 EKR therapeutics Inc: Key Financials

Figure 32 EKR therapeutics Inc: Segmental Revenue

Figure 33 EKR therapeutics Inc: Geographic Revenue

Figure 34 EUSA Pharma Inc: Key Financials

Figure 35 EUSA Pharma Inc: Segmental Revenue

Figure 36 EUSA Pharma Inc: Geographic Revenue

Figure 37 Swedish Orphan Biovitrum AB (publ): Key Financials

Figure 38 Swedish Orphan Biovitrum AB (publ): Segmental Revenue

Figure 39 Swedish Orphan Biovitrum AB (publ): Geographic Revenue

Figure 40 Soligenix: Key Financials

Figure 41 Soligenix: Segmental Revenue

Figure 42 Soligenix: Geographic Revenue

Figure 43 Daewoong co Ltd: Key Financials

Figure 44 Daewoong co Ltd: Segmental Revenue

Figure 45 Daewoong co Ltd: Geographic Revenue

Oral Mucositis Market

Oral Mucositis Market is expected to reach USD 1950.4 Million at CAGR of 4.3% during the forecast period of 2022-2030

Segmentation

By Cause Chemotherapy Radiotherapy Hematopoietic Stem Cell Transplantation Others
By End-User Hospitals Dental Clinics Oncology Hospitals Research Institutes

Key Players

  • Izun Pharmaceuticals Corporation
  • Shoreline Pharmaceuticals Inc
  • AMAG Pharmaceutical Inc
  • Innovation Pharmaceuticals
  • Himalaya Drug Company

Drivers

  • Rising incidences of cancer globally
  • Increasing oral mucositis drug development
Speak to Analyst Request a Free Sample

Oral Mucositis Market Overview


On paper, oral mucositis is a tissue swelling of the mouth. This health condition arises as a common side effect of radiation therapy or chemotherapy. Chemotherapy is usually undertaken by cancer patients as a cure. Thus, oral mucositis is mostly found in cancer patients. The condition arises when the radiation from therapy affects the mucosal lining of the gastrointestinal tract of the human body. This causes the decomposition of the mucosal cells. Moreover, this eventually leads to ulceration and inflammation of the mucosal lining. This is why the condition is called mucositis.


Oral mucositis is a gastrointestinal inflammation that can cause many problems in the human body. It can affect the general nutritional intake of a person. The mucosal lining is affected, which makes it difficult for an affected person to eat food. The open wounds of the mucosal lining also make you prone to infection. Oral mucositis can, therefore, have an adverse effect on the lifestyle of a patient. This market deals with the formulation and marketing of Oral Mucositis drugs worldwide. The Oral Mucositis Market deals with the diagnosis and treatment of cases of Oral Mucositis in different countries.


Since Oral Mucositis is a common health issue arising from cancer treatment and other factors, this market faces demand from different regions of the world. Cancer patients live everywhere in the world. Similarly, cancer hospitals and clinics offering radiation therapy are also all over the world. The customer base of the Oral Mucositis global Market is therefore diverse and dispersed. Since cases of Oral Mucositis surface every year, the Oral Mucositis Market witnesses demand every year. This demand does fluctuate from year to year based on different conditions. However, the Oral Mucositis Market faces more demand from countries that have a higher incidence of cancer.


COVID 19 Analysis

The COVID 19 pandemic has had different impacts on different sectors. For the healthcare sector, the COVID 19 pandemic has been both a bad and good influence. While the COVID 19 pandemic exposed the loopholes in the global healthcare infrastructure, it also pushed the world towards paying special focus towards strengthening the healthcare sector. For the Oral Mucositis Market, the COVID 19 pandemic has been similar. While the focus shifted to COVID 19 eradication, other diseases took a backseat.  Initially, in 2020, the demand for Oral Mucositis drugs fell slightly.


However, cancer is a life-threatening disease, and since cancer patients undergo chemotherapy for a prolonged period, the demand for Oral Mucositis drugs could not stay down for a long time. The demand for Oral Mucositis drugs went up, and the market recovered from the pandemic-induced dip. As the focus shifted to healthcare and survival, the pharmaceutical industry `leveled up. This meant that the Oral Mucositis Market also saw a period of growth in the pandemic period. In the post-pandemic period, the Oral Mucositis industry is expected to grow at a higher pace.

Market Dynamics 


The key drivers of the market  


There are many drivers of growth for the Oral Mucositis Market that influence the market from time to time. One of the major drivers of the Oral Mucositis Market is the increased detection of cancers. This holds true for cases of head and neck cancer case detection. Cancer can occur in any part of the body. In recent years, the number of necks and head cancer patients has gone up. This also creates a window for Oral Mucositis and is a demand window for Oral Mucositis industry. Another key driver of the Oral Mucositis Market is the increased section of the geriatric population. People are turning old and are prone to cancer because of their present lifestyle. Since all these factors increase the number of patients put every year under chemotherapy, they also influence the Oral Mucositis Market.


Significant opportunities of the market


Because of the way people live today and the number of carcinogenic substances they are exposed to, the number of cancer patients is on the increase today. As bad as this looks, this is a positive trend for the Oral Mucositis Market because this means that the dependence on the this market also goes up. The setup of cancer specialty hospitals and clinics is also a significant opportunity for this market growth. With the setup of new cancer specialty hospitals, there will be an increased demand for oral mucositis treatment.  Thus, there are positive oral mucositis market trends in the forecast period.


Market Restraints


There are many market restraints that the present oral mucositis drugs global market is witnessing. For example, a higher focus on COVID 19 has put all other diseases to the secondary. Even cancer is put forth as a secondary disease against the raging pandemic. Thus, the pandemic is a temporary restraint on the oral mucositis drugs market. On the other hand, the huge price of effective cancer treatment is also an indirect restraint of the oral mucositis market. As long as cancer treatments like chemotherapy will be pricy to afford for people, the oral mucositis treatment will not realize its full demand.


Market Challenges


Every market faces a set of challenges during its operation. The oral mucositis (om) market also faces many challenges in the forecast period. One of the biggest challenges that the oral mucositis om market faces is the lack of developed strong treatment drugs for advanced oral mucositis. While chemotherapy has advanced and becomes more powerful to tackle the different types of cancers that evolve, the same cannot be said for the drugs designed for the management of oral mucositis. There is plenty of room for further targeted research and development towards the formulation of better drugs for the management of oral mucositis.


Cumulative Growth Analysis


The cumulative growth analysis of the mucositis oral drugs global market in the report shows that the mucositis oral drug market reached a valuation of 2247 million US dollars in the year 2018. This mucositis oral drug market value increased in the year 2019. According to this market forecast, the cumulative growth rate of the oral mucositis market will be 7.1 percent in the next few years. This may not be a double-digit growth rate, but it is a healthy growth rate that will translate into considerable oral mucositis market growth in the forecast period. We can expect gradual growth of the market in the next few years.


Regional Market Summary:


Global Oral Mucositis Market Share by Region, 2018 (%)


Source: World Health Organization (WHO) 

Segment Overview 


The oral mucositis drugs market divides into different segments based on different characteristics and criteria. The segmentation of the oral mucositis drugs market is a great aid in oral mucositis drugs market analysis.  The various segments of the global oral mucositis drugs market are as follows-


By cause- The oral mucositis global market share divides into chemotherapy, radiotherapy, and others.


By end-users – By end-users, the oral mucositis global market share divides into hospitals, specialty clinics, research institutes, and dental clinics.


The regional segmentation of the oral global mucositis market is discussed in the next section.


Regional Overview


By regions, the oral mucositis market disperses over major regional markets of North America, Europe, and the Asia Pacific. Other regional markets of the oral mucositis industry are the Middle Eastern region and the African region. According to the oral mucositis market trends, the North American region, especially the USA, is the biggest market for oral mucositis drugs. The European region will be the second biggest market for oral mucositis drugs after the North American region. This is because the incidence of cancer is higher in these regions. The Asia Pacific region will show the biggest oral mucositis market trends in terms of growth. The Middle Eastern and African regions will also make significant contributions according to the oral mucositis industry forecast.


Competitive landscape 
There are various major key players in the oral mucositis global market that dominate the competitive landscape for the market. The key competitors are as follows-


  • Izun Pharmaceuticals Corporation

  • Shoreline Pharmaceuticals, Inc

  • AMAG Pharmaceutical Inc

  • Innovation Pharmaceuticals

  • Himalaya Drug Company


According to the oral mucositis market analysis, the competitors of the oral mucositis global market are dispersed over different countries of origin. These companies majorly contribute to the growth of this market on a global scale.

 

Recent Developments
To help the oral mucositis global market grow and secure opportunities, the key players are already channeling effort into the research and development of unique kinds of oral mucositis treatment. Key players are getting into mergers and acquisitions to fuel individual and cumulative market growth. The global oral mucositis treatment market forecast or overview is as follows:


  • Market Overview

  • COVID 19 Analysis

  • Market Dynamics

  • Segment Overview

  • Regional Analysis

  • Competitive Landscape


Recent Developments
The above report on the global oral mucositis drugs market explains the key drivers and growth indicators of the market. Secondly, it puts the trends of the market insight while predicting from 2020 to 2027. Thirdly, it also elaborates on the market characteristics of the oral mucositis treatment sector. Moreover, this report also covers the basic segmentation of the oral mucositis market and the dispersion of its regional markets worldwide. The report also talks about the complex, competitive landscape of the oral mucositis drugs market, with special attention to some of its recent developments. The oral mucositis drugs market forecast report is a well-formed and summarised report touching on different aspects.



Report Scope:
Report Attribute/Metric Details
  Market Size

  • 2018: USD 2,247 Million
  • 2027: Significant Value
  •   CAGR   7.1% (2019-2025)
      Base Year   2019
      Forecast Period   2020-2027
      Historical Data   2018
      Forecast Units   Value (USD Million)
      Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
      Segments Covered   Cause and End-User
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Izun Pharmaceuticals Corporation, Shoreline Pharmaceuticals, Inc, AMAG Pharmaceutical Inc, Innovation Pharmaceuticals, The Himalaya Drug Company, Access pharmaceuticals, EKR therapeutics Inc, EUSA Pharma Inc, Swedish Orphan Biovitrum AB (publ), Soligenix, and Daewoong Co. Ltd.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers

  • Rising incidences of cancer globally
  • Increasing oral mucositis drug development


  • Speak to Analyst Ask for Customization